News & Analysis: Lillibridge’s final recap
SALE TO VENTAS WILL PROVIDE GROWTH CAPITAL By John Mugford The pending $300 million to $400 million sale of Lillibridge Healthcare Services Inc. and its vast medical office building (MOB) portfolio to publicly traded Ventas Inc. (NYSE: VTR) made quite a splash in various news outlets in the days following the big announcement. Should the […]